Cao et al. combined data from 37 trials, with the primary endpoint being the identification of any cancer, and found GLP-1 RAs were not associated with an increased risk of cancer (OR 1.03 [95% CI 0.95–1.12]; p = 0.41) [27]. This evidence concerns the gene GLP1R and cancer.